KAD Industries LLC is the US business development and investment arm of a vertically integrated pharmaceutical and industrial enterprise — connecting WHO GMP manufacturing, international trade corridors, and regulatory access across 25+ markets.
Explore ServicesStart a ConversationRegistered in Wyoming, USA, KAD Industries LLC operates at the intersection of pharmaceutical manufacturing, international trade, and industrial investment. We structure ventures, open regulated markets, and place production capacity where our clients need it.
Behind KAD stands operating leadership from a WHO GMP-compliant pharmaceutical pellet manufacturer exporting to more than 25 markets, and a GCC-based sourcing and indenting consultancy — giving our partners direct, working access to real factories, real distribution, and real regulatory pathways.

One coordinated command over manufacturing capacity, distribution reach, and market access. From GCC pharmaceutical plants to distribution partners across Asia, Africa, the Middle East, and the Americas — KAD aligns the entire chain behind every mandate.
Every service line is backed by hands-on manufacturing, trade, and regulatory execution — not consulting theory.

Facility design, WHO GMP compliance programs, technology transfer, and Lean Six Sigma-driven operational excellence for pharmaceutical and nutraceutical plants.

Trade-corridor strategy, duty optimization under GAFTA and GCC frameworks, buyer-seller matchmaking, and live trade intelligence across HS-coded commodities.

Dossier preparation and market authorization across GCC and MENA — active registration consulting in Oman, Yemen, Pakistan, Bangladesh, and Lebanon.

Formulation, contract manufacturing placement, and go-to-market structuring for supplements, gummies, softgels, and specialty dosage forms.

API, excipient, and raw-material sourcing through an indenting model — commission-based, no inventory risk, with vetted suppliers across Asia and the GCC.

Feasibility, CAPEX/OPEX modeling, and deal structuring for greenfield plants and cross-border ventures — including US market entry for international manufacturers.

End-to-end pharmaceutical integration: fermentation and active ingredient synthesis through finished dosage formulation and pharmacy-level distribution. 4-facility network across GCC, stake holdings in specialty pharmaceuticals reaching 25+ markets.

Shams Free Zone, Sharjah — commission-based indenting and sourcing consultancy for raw materials and industrial goods across GCC and MENA corridors.

Wyoming, USA — the group's American arm for new ventures, partnerships, and investment structuring in the US market.

Our anchor manufacturing operates under internationally recognized quality frameworks, with fluid-bed pellet technology, validated processes, and Lean Six Sigma Black Belt-led continuous improvement.
From dossier to dispatch, every engagement is built to survive regulatory scrutiny in the markets that matter.
Manufacturing mandates, registration projects, sourcing briefs, or investment discussions — reach the principals directly.
[email protected]